您使用提示模式 关闭

XBI - SPDR S&P Biotech ETF (USD) (US78464A8707)

The comparsion limit has been reached: only 5 tools has been added. To add a new one, please remove one of the existing tools.

使用 Cbonds Watchlist 查找、保存和跟踪投资工具

有了 Cbonds Watchlist，您可以随时了解投资信息，做出明智决策！

Watchlist
需要 访问

全选 清除所有
 
(%)
US78464A8707
XBI ISIN
交易所交易基金 (ETF)
基金类型
SPDR State Street Global Advisors
提供商
157,39 USD
每股资产净值 | 2026-08-14
2006-01-31
成立日期
4 每年的次数
股息的支付
CEOILS
CFI
XBI
代码
Formed
Status
Equity
投资项目
Biotech
部门
USA
地区分布
S&P Biotechnology Select Industry Index
基准
0.35 %
总成本比率
10.602,03 百万 USD
基金资产总量 | 2026-08-13
否
UCITS
1 / 3 (11/09/2015)
拆分

收益率 在 2026-08-14, NYSE Arca

  • YTD
    5,06 %
  • 1M
    -7,93 %
  • 3M
    1,65 %
  • 6M
    11,2 %
  • 1Y
    62,15 %
  • 3Y
    51,47 %
  • 5Y
    0,91 %
  • 10Y
    143,19 %
按交换价格计算，包括收入支付

最新数据在
添加比较项目
从
至
ADD-IN
Cbonds 加载项 API
债券数据 API

报价 (XBI)

探索最全面的数据库

1 000 000

债券

100 000

股票

175 910

ETF & Funds

8万

指数

以最有效的方式跟踪您的投资组合

  • 债券筛选器
  • 观察列表
  • Excel 附加组件
请求访问

价格动态的变化

Fund profile

The SPDR S&P Biotech ETF seeks to replicate as closely as possible the price and yield performance of the S&P Biotechnology Select Industry Index by investing in a portfolio comprised primarily of U.S. companies in the biotechnology sector

XBI profile

The SPDR S&P Biotech ETF (USD) is a(n) Equity Exchange Traded Funds (ETF) seeks to invest in Biotech sector located in USA. The SPDR State Street Global Advisors fund’s base currency is USD and the share class was registered 31.01.2006 with unique ISIN - US78464A8707. Main exchange is NYSE Arca and ticker symbol is XBI. The total expense ratio is 0.35%. The SPDR S&P Biotech ETF (USD) pays dividends 4 time(s) per year.

结构 XBI 在 2026-08-13

下载结构至 Excel 文档
证券 值
TWIST BIOSCIENCE CORP 1,76%
ORUKA THERAPEUTICS INC 1,61%
APOGEE THERAPEUTICS INC 1,55%
PRAXIS PRECISION MEDICINES I 1,46%
KYMERA THERAPEUTICS INC 1,39%
NATERA INC 1,37%
DIANTHUS THERAPEUTICS INC 1,37%
PROTAGONIST THERAPEUTICS INC 1,36%
HALOZYME THERAPEUTICS INC 1,36%
REVOLUTION MEDICINES INC 1,33%
MODERNA INC 1,32%
INSMED INC 1,31%
CG ONCOLOGY INC 1,3%
SPYRE THERAPEUTICS INC 1,29%
RHYTHM PHARMACEUTICALS INC 1,29%
REGENERON PHARMACEUTICALS 1,28%
ERASCA INC 1,27%
TRAVERE THERAPEUTICS INC 1,25%
VAXCYTE INC 1,23%
ROIVANT SCIENCES LTD 1,22%
RELAY THERAPEUTICS INC 1,2%
AMGEN INC 1,18%
BIOMARIN PHARMACEUTICAL INC 1,16%
ARROWHEAD PHARMACEUTICALS IN 1,15%
BRIDGEBIO PHARMA INC 1,15%
SCHOLAR ROCK HOLDING CORP 1,15%
COGENT BIOSCIENCES INC 1,13%
VIKING THERAPEUTICS INC 1,13%
VERTEX PHARMACEUTICALS INC 1,13%
INCYTE CORP 1,09%
GILEAD SCIENCES INC 1,08%
ACADIA PHARMACEUTICALS INC 1,08%
UNIQURE NV 1,08%
ALKERMES PLC 1,07%
ABBVIE INC 1,06%
CYTOKINETICS INC 1,04%
CRISPR THERAPEUTICS AG 1,04%
BIOGEN INC 1,03%
DYNE THERAPEUTICS INC 1,03%
IMMUNOVANT INC 1,03%
MADRIGAL PHARMACEUTICALS INC 1,03%
SELLAS LIFE SCIENCES GROUP I 1,02%
KRYSTAL BIOTECH INC 1%
MIRUM PHARMACEUTICALS INC 1%
SUMMIT THERAPEUTICS INC 1%
TG THERAPEUTICS INC 0,98%
CELCUITY INC 0,93%
PTC THERAPEUTICS INC 0,93%
GRAIL INC 0,93%
ULTRAGENYX PHARMACEUTICAL IN 0,93%
EXELIXIS INC 0,92%
IMMUNITYBIO INC 0,91%
IOVANCE BIOTHERAPEUTICS INC 0,91%
BIOCRYST PHARMACEUTICALS INC 0,9%
NEUROCRINE BIOSCIENCES INC 0,89%
UNITED THERAPEUTICS CORP 0,88%
BEAM THERAPEUTICS INC 0,86%
CELLDEX THERAPEUTICS INC 0,83%
VIRIDIAN THERAPEUTICS INC 0,83%
DENALI THERAPEUTICS INC 0,83%
IDEAYA BIOSCIENCES INC 0,81%
SAREPTA THERAPEUTICS INC 0,79%
IMMUNOME INC 0,76%
ALNYLAM PHARMACEUTICALS INC 0,74%
DISC MEDICINE INC 0,73%
VERA THERAPEUTICS INC 0,73%
IONIS PHARMACEUTICALS INC 0,73%
ARCUTIS BIOTHERAPEUTICS INC 0,72%
ARCUS BIOSCIENCES INC 0,71%
TANGO THERAPEUTICS INC 0,71%
MINERALYS THERAPEUTICS INC 0,7%
ADMA BIOLOGICS INC 0,7%
RECURSION PHARMACEUTICALS A 0,7%
INTELLIA THERAPEUTICS INC 0,65%
SYNDAX PHARMACEUTICALS INC 0,64%
AGIOS PHARMACEUTICALS INC 0,64%
NURIX THERAPEUTICS INC 0,64%
PALVELLA THERAPEUTICS INC 0,61%
VERACYTE INC 0,61%
NOVAVAX INC 0,59%
KODIAK SCIENCES INC 0,57%
BIOHAVEN LTD 0,54%
CAREDX INC 0,52%
VERICEL CORP 0,51%
STOKE THERAPEUTICS INC 0,47%
ABSCI CORP 0,47%
CULLINAN THERAPEUTICS INC 0,45%
PRECIGEN INC 0,44%
ORIC PHARMACEUTICALS INC 0,43%
XENCOR INC 0,43%
VIR BIOTECHNOLOGY INC 0,43%
CORVUS PHARMACEUTICALS INC 0,43%
ANAPTYSBIO INC 0,42%
HYPERLIQUID STRATEGIES 0,41%
REPLIMUNE GROUP INC 0,4%
FIRST TRACKS BIOTHERAPEUTICS 0,39%
VOR BIOPHARMA INC 0,39%
AVALO THERAPEUTICS INC 0,38%
ZENAS BIOPHARMA INC 0,38%
INHIBRX BIOSCIENCES INC 0,37%
显示所有 隐藏
Other - %

其他 ETF 和基金提供商

相关 ETF 和基金

  • {{ item.etf.ttl }}
    {{ item.nav_usd }} 百万
    资产净值
    {{ item.expense_ratio }}
    总成本比率
你必须 注册 才能获得访问权